Business Wire

SBC Medical Appoints Dr. Steven R. Cohen as Medical Strategy Advisor to Accelerate Global Expansion

Share

SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical”), a global provider of comprehensive consulting and management services to the medical corporations and their clinics, today announced the appointment of Dr. Steven R. Cohen, a globally recognized leader in plastic and craniofacial surgery, as Medical Strategy Advisor. His appointment marks a significant step in the company’s strategy to expand its global footprint and enhance its medical excellence.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250714547888/en/

Dr. Cohen

Dr. Cohen is the Founder of Faces+, an advanced aesthetic and reconstructive surgery center in San Diego, California. With over 30 years of clinical experience, he is widely known for his pioneering work in regenerative aesthetics, including the clinical application of fat-derived stem cells, skeletal facial aesthetic surgery, and the integration of artificial intelligence into medical innovation. Dr. Cohen is also the inventor of the internal craniofacial distraction device and LipoCube, both of which have become global standards in the field.

Recognized by Newsweek as one of “America’s Best Plastic Surgeons,” Dr. Cohen has authored numerous scientific publications and textbooks and is a sought-after speaker at international conferences. He is also a Clinical Professor at the University of California, San Diego, and an active member of several global societies, including the American Society of Plastic Surgeons (ASPS).

Following its Nasdaq listing in September 2024, SBC Medical has accelerated its global growth initiatives. With Dr. Cohen’s participation, the company aims to elevate its medical quality, strengthen brand positioning in international markets, expand academic collaborations, and enhance its physician training programs—further solidifying its presence as a truly global medical group.

Message from Yoshiyuki Aikawa, CEO of SBC Medical
“It is a great honor to welcome Dr. Steven R. Cohen, a world-class clinician, to our team. His deep expertise and global perspective will play a transformative role in elevating our medical standards, physician education, and brand development. We look forward to his contributions as we enter a new phase of growth.”

Message from Dr. Steven R. Cohen
“I am honored to join SBC Medical, a company that is not only expanding rapidly but also committed to innovation and patient-centered care. SBC Medical’s investment in physician education and international collaboration resonates deeply with my own values. I look forward to contributing to the advancement of safer, scientifically grounded, and aesthetically refined regenerative aesthetics on a global scale.”

About Dr. Steven R. Cohen (Partial Profile)

  • Board-certified in Plastic Surgery and Craniofacial Surgery
  • Founder and Medical Director, Faces+ (San Diego, California)
  • Clinical Professor of Plastic Surgery, University of California, San Diego
  • Inventor of the internal craniofacial distraction device and LipoCube
  • Recognized as one of America’s Best Plastic Surgeons by Newsweek
  • Global authority in facial reconstruction, stem cell therapy, and 3D surgical simulation
  • Frequent keynote speaker at international academic societies; author of multiple books and peer-reviewed articles

For more information about Dr. Steven R. Cohen, please visit: https://www.facesplus.com/about/dr-steven-r-cohen/

About SBC Medical

SBC Medical, headquartered in Irvine, California and Tokyo, Japan, owns and provides management services and products to cosmetic treatment centers. The Company is primarily focused on providing comprehensive management services to franchisee clinics, including but not limited to advertising and marketing needs across various platforms (such as social media networks), staff management (such as recruitment and training), booking reservations for franchisee clinic customers, assistance with franchisee employee housing rentals and facility rentals, construction and design of franchisee clinics, medical equipment and medical consumables procurement (resale), the provision of cosmetic products to franchisee clinics for resale to clinic customers, licensing of the use of patent-pending and non-patented medical technologies, trademark and brand use, IT software solutions (including but not limited to remote medical consultations), management of the franchisee clinic’s customer rewards program (customer loyalty point program), and payment tools for the franchisee clinics.

For more information, visit https://sbc-holdings.com/

View source version on businesswire.com: https://www.businesswire.com/news/home/20250714547888/en/

Contacts

SBC Medical Group Holdings Incorporated (Asia)
Hikaru Fukui / Head of Investor Relations E-mail: ir@sbc-holdings.com
Daisuke Murakami / Public Relations E-mail: pr@sbc.or.jp

ICR LLC (In the US)
Bill Zima / Managing Partner Email: bill.zima@icrinc.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

www.businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Cessna Skyhawk Soars With Enhanced Efficiency: Solid-State Dual Electronic Ignition System Introduced to the Industry-leading Piston14.7.2025 19:00:00 EEST | Press release

The industry-leading training aircraft, the Cessna Skyhawk, now features a dual electronic ignition system (dual EIS), enhancing maintenance, efficiency and overall operation of the single-engine, high-wing piston. The dual Lycoming electronic ignition system is now standard on all new Cessna Skyhawk aircraft. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250714759359/en/ Cessna Skyhawk soars with enhanced efficiency: solid-state dual electronic ignition system introduced to the industry-leading piston (Photo Credit: Textron Aviation) The Cessna Skyhawk is designed and produced by Textron Aviation Inc., a Textron Inc. (NYSE: TXT) company. The dual EIS replaces the previous dual magneto ignition system on the Skyhawk, incorporating advanced electronic components and reducing the number of internal moving parts to optimize operation. This solid-state electronic technology improves maintenance intervals, fuel efficiency and en

The 2025 Empire State Building Run-Up Returns Oct. 814.7.2025 18:48:00 EEST | Press release

The Empire State Building (ESB) announced today general lottery registration for the annual Empire State Building Run-Up (ESBRU) on Oct. 8, 2025, at 8 p.m. ESB also announced the ESBRU will be presented by NYU Langone Health and powered by the Challenged Athlete’s Foundation. General lottery registration will be open from July 14 through July 28, 2025. In the 47th annual Run-Up, 225 runners will race up the iconic building’s 1,576 stairs to the world-famous Observatory. This year’s heats will include elite men and women, media, celebrities, New York City real estate brokers, building tenants, CAF athletes, members of the NYPD and FDNY, and the public, among others. On July 30, registered runners will be notified of their race status with participation costs of $175 per runner to be charged only upon acceptance from the lottery. “We are delighted to welcome NYU Langone Health as our new sponsor and look forward to the arrival of athletes from across the globe for the world’s most famous

Taicang: A Model for China-Europe ESG Cooperation14.7.2025 17:11:00 EEST | Press release

Located in the Yangtze River Delta, Taicang City in Jiangsu Province is known as the “Hometown of German Enterprises in China.” At the recent 2nd Sino-European Corporate ESG Best Practice Conference, Taicang received the prestigious “Zero-Carbon City” Best Practice Award, further solidifying its reputation as a benchmark for green urban transformation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250714458209/en/ A glimpse of Taicang City, Jiangsu Province, China. According to the jury, “By integrating ESG indicators into its urban development strategy, Taicang has demonstrated visionary leadership and has become a model for sustainable city and industrial development.” In response to the global challenges of climate change and sustainable growth, Taicang has proactively aligned with China’s “dual carbon” strategy. It has positioned itself as a modern garden city driven by green development, integrating ESG principles into

Andersen Consulting Strengthens Platform with Addition of Baufest14.7.2025 17:00:00 EEST | Press release

Andersen Consulting expands its digital transformation capabilities through a Collaboration Agreement with Baufest, a global digital product design and development firm. With more 30 years of experience and offices across the Americas and Europe, Baufest is recognized for combining cutting-edge technology with a deep understanding of business strategy and user experience. The firm offers a comprehensive range of services including business design, digital products development, data and applied AI, and cybersecurity. Baufest serves enterprise clients across key industries such as banking and finance, retail, energy, and healthcare, with a focus on driving measurable business outcomes through agile, scalable, and ethical tech practices. “Our collaboration with Andersen Consulting represents a transformational step forward in the services we offer,” said Ángel Pérez Puletti, managing director of Baufest. “Andersen’s full suite of multidisciplinary services builds on Baufest’s deep technic

Kihealth Wins Innovation of the Year at ADA 85th Scientific Sessions for Groundbreaking Diabetes Diagnostic14.7.2025 16:04:00 EEST | Press release

Kihealth, a leader in molecular diagnostics, today announced it has won the Innovation of the Year challenge at the American Diabetes Association’s 85th Scientific Session held in Chicago. Kihealth’s pioneering liquid-biopsy test, which measures the rate of pancreatic beta‑cell death, earned top honors among five finalists for its potential to revolutionize early diabetes detection. Dubbed the “Super Bowl of diabetes innovation,” this prestigious award has firmly established Kihealth and its products in the spotlight. The honor follows a live pitch to a panel of expert judges and a global audience of clinicians, researchers, and industry leaders. In winning first place, Kihealth stood out for delivering a novel diagnostic that provides patients and clinicians with a critical early window into metabolic health – years before glucose or A1c abnormalities appear prnewswire.com. Key Highlights & Immediate Impact Surge in physician engagement: Following the win, Kihealth has received new co

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye